Literature DB >> 53069

On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.

D F Wentworth, R Wolfenden.   

Abstract

In contrast to the rapid inhibition of bacterial cytidine deaminase by 3,4,5,6-tetrahydrouridine, the onset of inhibition of the enzyme from human liver was found to be relatively slow. Inhibition was found to be reversible, and the corrected rate constants for binding (kon = 2.4 x 10(4) M-1 sec-1) and release (koff = 5.6 x 10(-4) sec-1) were in reasonable agreement with a Ki value (2.9 x 10(-8) M) measured separately under steady-state conditions, which was several orders of magnitude lower than estimates previously reported in the literature. Rates of binding and release of this potential transition state analogue were not appreciably affected by the substitution of deuterium oxide for solvent water. The slow onset of inhibition, which was also observed for cytidine deaminase from HeLa cells, suggests that structural reorganization precedes the formation of a stable enzyme-inhibitor complex. 6-Azacytidine, which favors a "high-anti" configuration at the glycosidic bond, was found to be active as a substrate for cytidine deaminase, with a turnover number exceeding that of cytidine. 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine, which is restricted to the "syn" configuration, was found to be without activity as a substrate or an inhibitor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53069     DOI: 10.1021/bi00694a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.

Authors:  J Laliberté; V E Marquez; R L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Targeting the epigenome in malignant pleural mesothelioma.

Authors:  Kaitlin C McLoughlin; Andrew S Kaufman; David S Schrump
Journal:  Transl Lung Cancer Res       Date:  2017-06

3.  A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine.

Authors:  Nicole M Anders; Teresia M Wanjiku; Ping He; Nilofer S Azad; Michelle A Rudek
Journal:  Biomed Chromatogr       Date:  2015-08-17       Impact factor: 1.902

4.  The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.

Authors:  W R Osborne; C R Scott
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

5.  Fluorescent labeling of tRNA dihydrouridine residues: Mechanism and distribution.

Authors:  Jaskiran Kaur; Monika Raj; Barry S Cooperman
Journal:  RNA       Date:  2011-05-31       Impact factor: 4.942

Review 6.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

7.  Cytidine deaminase can deaminate fused pyrimidine ribonucleosides.

Authors:  Paul T Ludford; Yao Li; Shenghua Yang; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2021-07-21       Impact factor: 3.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.